Clinical Trial

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria

Name: A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria — clinical trial record (NCT07241234)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The primary purpose of this study is to assess the safety and tolerability of AG-181 in subjects with Phenylketonuria (PKU).

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-25

Trial Details

NCT Number	NCT07241234
Lead Sponsor	Agios Pharmaceuticals, Inc.
Conditions	Phenylketonuria
Enrollment	20 participants
Start Date	2026-04-17
Primary Completion	2028-01-17 (estimated)
Study Completion	2028-01-17 (estimated)
Updated on ClinicalTrials.gov	2026-07-30